$TRON Low float/No RS/$100M Healthcare Acquisition Play:

New Post Public Reply Private Reply Replies (0) Message Board
Mysterium
393
$TRON Low float/No RS/$100M Healthcare Acquisition Play:


*For full PR history, including the coming selected excerpts, please follow this link where they have been compiled from otcmarkets:

https://investorshangout.com/post/view?id=5269652




**PR Highlights(not including BOD info, removal of custodianship, addition/removal of accounting or legal services, etc):



“iMedScan’s proprietary technology will generate a twenty-five percent (25%) reduction in patient insurance rejections or denials from insurance payors,” Morentin said. He continued, “changes in the healthcare industry have considerably lowered profit margins and increase the costs of healthcare to consumers; we believe our technology will create significant cost reductions that will benefit both insurers and insureds.”


" iMedScan finalized a test program with Change America, formerly Emdeon Corporation, utilizing an electronic data interchange for verifying and
validating patients’ health insurance. “We estimate a fifty percent (50%) net profit recapture from each medical office that adopts our technology,” Morentin noted. Currently, in addition to traditional medical offices, iMedScan is focusing on the further development and commercialization of kiosk devices hosting the company’s scanning solution."



.....25% reduction + 50% recapture.....




"Toron Management has elected not to proceed forward with a previously contemplated reverse stock split.

Rene Ortiz Morentin, President, stated “based upon the current business opportunities that are being considered, a reverse split would not be in the best interest of Toron and its shareholders”."



"Additionally, the Company has filed an amendment of the articles of incorporation, with the board of director’s approval, with the Secretary of State of Nevada to reduce its total authorized shares of common stock from 2,500,000,000 to 1,000,000,000. Mr. Ortiz Morentin stated “I can see no reason to
support a dilution event for Toron shareholders”."


(Float has remained at 299M)



"After our long and difficult road to finalize the complex documentation for the acquisition of The InMed Group, such was completed on October 10, 2018. Our acquisition was extremely complex given that we were acquiring numerous operating entities in 2 states and ensuring that all required permits and licenses remained intact. Our partner, Flagship Properties, has stood by our side during this process and we look forward to working with Flagship in the future," stated Rene Ortiz Morentin, Toron's Chief Executive Officer.

Under the terms of the transaction, Pantheon Partners SRL has agreed to transfer 100 Million shares of Toron, Inc. stock to Flagship Properties, LLC, and 100 Million shares of Toron, Inc. stock to InMed Group.

"Our transition team is poised to add efficiencies to the operations of The InMed Group to strengthen and grow cash flow. Moreover, we are negotiating with several financial institutions to provide Toron with a substantial operating line of credit to further add efficiencies for InMed operations and facilitate Toron's continued growth," further added Ortiz Morentin."




"“We are pleased to announce that Toron has accepted and executed a Letter of Intent for a $10 million working capital facility from a privately held finance company specializing in financing healthcare providers in the United States. With this working capital facility in place, we can
implement our strategic plans for operations and we shall be poised to explore additional acquisition opportunities to add to our base of operations,” stated Rene Ortiz Morentin, Toron’s Chief Executive Officer.

Additionally, the Company has engaged Sterling Issuer Services to prepare and file with the Securities and Exchange Commission a Form 8-K."


"On November 14, 2018, Toron received a letter confirming our acquisition of the InMed Group. Jacques Jarry, Founder and Chief Executive Officer, stated “It is our pleasure to confirm our Agreements for the completion of the acquisition of The InMed Group, Inc. and its affiliated entities.” Mr. Jarry further added “As you are aware, there are necessary State and Federal
notifications required regarding the change in control for the InMed Group operating entities. This process can take 30-45 days, however, we anticipate such on approximately Dec 21st, 2018. We are pleased to become part of the Toron family and towards building a stronger and expanded healthcare network.”




299M float. (value estimated) $100M healthcare acquisition finalized. 8-k on the way. Board of Director integration from InMed, etc scheduled for late November. State and Federal paperwork for InMed/Toron deal anticipated to be transitioned on approximately 12/21/18. LOI accepted and executed for additional $10M working capital line of credit for operations and additional acquisitions (Note: estimated $100M InMed deal had LOI for $10.9M).










Please also see the following:


Once open to "All Forums", click on "Toron Investors", then "InMed Group Acquisition", then scroll to read John Reiner's "Ultimate DD" post:

http://toroninc.com/forums/





Also, make sure to take a look at MovingOn's updated checklist, posted prior by UnHuggy:


https://investorshangout.com/post/view?id=5268873


Read More: https://investorshangout.com/post/view?id=526...z5Xn5P23zf
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 176

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 140

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 578

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Response to Aluminium Tariff Threats and Implications

Updated Category News Views 121

Market Insights on Aluminium Pricing and Tariffs The aluminium market has been under scrutiny as recent events unfold regarding potential tariffs on Canadian imports. Despite rising aluminium prices for U.S. consumers since the presidential election, the increase has remained relatively moderate. This suggests that industry players are not overly concerned about the...

Continue Reading
Understanding the Booming Healthcare Asset Management Market

Updated Category News Views 230

Healthcare Asset Management Market Overview The Healthcare Asset Management market has been experiencing remarkable growth, with projections estimating its value to exceed USD 166.82 billion. This rapid expansion is driven by an impressive compound annual growth rate (CAGR) of 23.1% from 2024 to 2032. This article delves into the reasons behind this growth and what the...

Continue Reading
T1 Energy Inc. Faces Shareholder Investigation: What You Need to Know

Updated Category News Views 454

Understanding the Investigation of T1 Energy Inc. T1 Energy Inc. (NYSE: TE) is currently the focus of an important investigation launched by Purcell & Lefkowitz LLP, aimed at safeguarding the rights of its shareholders. This inquiry is centered on whether the directors have acted in accordance with their fiduciary duties regarding significant recent corporate actions. Why...

Continue Reading
Kimberly-Clark's Strategic Move to Shape Health and Wellness Market

Updated Category News Views 183

Kimberly-Clark's Transformative Acquisition In a remarkable move to bolster its position in the personal care products sector, Kimberly-Clark Corporation is poised to acquire Kenvue. This acquisition will create a formidable entity within the health and wellness market, valued at an impressive $32 billion. Kimberly-Clark, recognized for its commitment to sustainability...

Continue Reading
ADC Therapeutics Welcomes New Talent with Employee Grants

Updated Category News Views 106

ADC Therapeutics Expands Team with New Inducement Grant ADC Therapeutics SA (NYSE: ADCT), a leader in the field of antibody drug conjugates (ADCs), recently made headlines by offering a grant of options to acquire 6,000 of the company's common shares to a newly hired employee. This strategic move highlights the company's commitment to attracting top talent essential for...

Continue Reading